Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Issues reported with supply of lactating cow intramammary antibiotics
Ubro Yellow Milking Cow Intramammary Suspension is one of the products to be suspended.

VMD updates list of available products

The Veterinary Medicines Directorate (VMD) has reported supply problems with certain lactating cow intramammary antibiotics.

The following is a list of lactating cow intramammary antibiotics that Marketing Authorisation Holders (MAHs) have noted availability problems for, along with anticipated resolution dates for each product:

Product Anticipated resolution date
Synulox Lactating Cow Intramammary Suspension (42058/4143) First quarter of 2021
Tetra-Delta Intramammary Suspension (42058/4152) First half of 2021
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) February 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035) December 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534) End of November 2020
Cobactan MC Intramammary Suspension for Lactating Cows (01708/4444)* December 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424) January 2021
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)* product discontinued – no return date

These lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*

Please note: VMD states that the products marked with a '*' are defined as a Highest Priority Critically Important Antibiotics for human medicine and, under the Red Tractor farm assurance scheme for beef and dairy, should be used as a last resort and supported by sensitivity and/or diagnostic testing.

For further details of the supply situation for individual UK-authorised products, please contact the MAH or a wholesale dealer.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.